PD-L1 in melanoma: facts and myths

by Mandalà, Mario, Merelli, Barbara, Massi, Daniela
Published in Melanoma Manag (2016)

Melanoma brain metastases: review of histopathological features and immune-molecular aspects

by Salvati, Lorenzo, Mandalà, Mario, Massi, Daniela
Published in Melanoma Manag (2020)

Optimizing use of opiates in the management of cancer pain

by Mandalà, Mario, Moro, Cecilia, Labianca, Roberto, Cremonesi, Marco, Barni, Sandro
Published 2006

Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?

by Indini, Alice, Roila, Fausto, Grossi, Francesco, Massi, Daniela, Mandalà, Mario
Published in Am J Clin Dermatol (2021)

Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications

by Indini, Alice, Grossi, Francesco, Mandalà, Mario, Taverna, Daniela, Audrito, Valentina
Published in Biomedicines (2021)

Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches

by Palmieri, Giuseppe, Colombino, Maria, Casula, Milena, Manca, Antonella, Mandalà, Mario, Cossu, Antonio
Published in Curr Oncol Rep (2018)

AKT-ions with a TWIST between EMT and MET

by Tang, Huifang, Massi, Daniela, Hemmings, Brian A., Mandalà, Mario, Hu, Zhengqiang, Wicki, Andreas, Xue, Gongda
Published in Oncotarget (2016)

Dabrafenib and Trametinib prolong coagulation through the inhibition of tissue factor in BRAF(v600e) mutated melanoma cells in vitro

by Scatena, Cristian, Franceschi, Sara, Franzini, Maria, Sanguinetti, Chiara, Romiti, Nadia, Caponi, Laura, Mandalà, Mario, Mazzanti, Chiara Maria, Naccarato, Antonio Giuseppe
Published in Cancer Cell Int (2019)

Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action

by Khorana, Alok A., Streiff, Michael B., Farge, Dominique, Mandala, Mario, Debourdeau, Philippe, Cajfinger, Francis, Marty, Michel, Falanga, Anna, Lyman, Gary H.
Published 2009

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study

by Barni, Sandro, Labianca, Roberto, Agnelli, Giancarlo, Bonizzoni, Erminio, Verso, Melina, Mandalà, Mario, Brighenti, Matteo, Petrelli, Fausto, Bianchini, Carlo, Perrone, Tania, Gasparini, Giampietro
Published 2011

Association of Socioeconomic Status With Breslow Thickness and Disease-Free and Overall Survival in Stage I-II Primary Cutaneous Melanoma

by Mandalà, Mario, Imberti, Gian Lorenzo, Piazzalunga, Dario, Belfiglio, Maurizio, Lucisano, Giuseppe, Labianca, Roberto, Marchesi, Lorenzo, Merelli, Barbara, Robone, Silvana, Poletti, Paola, Milesi, Laura, Tondini, Carlo
Published 2011

Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients

by De Logu, Francesco, Galli, Francesca, Nassini, Romina, Ugolini, Filippo, Simi, Sara, Cossa, Mara, Miracco, Clelia, Gianatti, Andrea, De Giorgi, Vincenzo, Rulli, Eliana, Cossu, Antonio, Massi, Daniela, Mandalà, Mario
Published in Cells (2021)

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma

by Audrito, Valentina, Managò, Antonella, Zamporlini, Federica, Rulli, Eliana, Gaudino, Federica, Madonna, Gabriele, D'Atri, Stefania, Antonini Cappellini, Gian Carlo, Ascierto, Paolo Antonio, Massi, Daniela, Raffaelli, Nadia, Mandalà, Mario, Deaglio, Silvia
Published in Oncotarget (2018)

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy

by Teterycz, Pawel, Czarnecka, Anna M., Indini, Alice, Spałek, Mateusz J., Labianca, Alice, Rogala, Pawel, Cybulska-Stopa, Bożena, Quaglino, Pietro, Ricardi, Umberto, Badellino, Serena, Szumera-Ciećkiewicz, Anna, Falkowski, Slawomir, Mandala, Mario, Rutkowski, Piotr
Published in Cancers (Basel) (2020)

Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective

by Ombra, Maria Neve, Paliogiannis, Panagiotis, Stucci, Luigia Stefania, Colombino, Maria, Casula, Milena, Sini, Maria Cristina, Manca, Antonella, Palomba, Grazia, Stanganelli, Ignazio, Mandalà, Mario, Gandini, Sara, Lissia, Amelia, Doneddu, Valentina, Cossu, Antonio, Palmieri, Giuseppe
Published in Nutr Metab (Lond) (2019)

Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer

by Gregorc, Vanesa, Lazzari, Chiara, Mandalá, Mario, Ippati, Stefania, Bulotta, Alessandra, Cangi, Maria Giulia, Khater, Abdelrahman, Viganò, Maria Grazia, Mirabile, Aurora, Pecciarini, Lorenza, Ogliari, Francesca Rita, Arrigoni, Gianluigi, Grassini, Greta, Veronesi, Giulia, Doglioni, Claudio
Published in Cancers (Basel) (2021)

PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p

by Audrito, Valentina, Serra, Sara, Stingi, Aureliano, Orso, Francesca, Gaudino, Federica, Bologna, Cinzia, Neri, Francesco, Garaffo, Giulia, Nassini, Romina, Baroni, Gianna, Rulli, Eliana, Massi, Daniela, Oliviero, Salvatore, Piva, Roberto, Taverna, Daniela, Mandalà, Mario, Deaglio, Silvia
Published in Oncotarget (2017)

Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study

by Casula, Milena, Paliogiannis, Panagiotis, Ayala, Fabrizio, De Giorgi, Vincenzo, Stanganelli, Ignazio, Mandalà, Mario, Colombino, Maria, Manca, Antonella, Sini, Maria Cristina, Caracò, Corrado, Ascierto, Paolo Antonio, Satta, Rosanna Rita, Lissia, Amelia, Cossu, Antonio, Palmieri, Giuseppe
Published in BMC Cancer (2019)

SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study

by Mandala, Mario, Lorigan, Paul, De Luca, Matilde, Bianchetti, Andrea, Merelli, Barbara, Bettini, Anna Cecilia, Bonomi, Lucia, Nahm, Sharon, Vitale, Maria Grazia, Negrini, Giorgia, Di Croce, Andrea, Ascierto, Paolo Antonio, Rulli, Eliana, Tondini, Carlo Alberto
Published in J Immunother Cancer (2021)

coBRIM: a phase 3, double-blind, placebo-controlled study of vemurafenib versus vemurafenib + cobimetinib in previously untreated BRAF(V600) mutation–positive patients with unresec...

by Ascierto, Paolo A, McArthur, Grant A, Dréno, Brigitte, Larkin, James, Liszkay, Gabriella, Maio, Michele, Mandala, Mario, Demidov, Lev, Stroyakovskiy, Daniil, Thomas, Luc, de la Cruz-Merino, Luis, Atkinson, Victoria, Dutriaux, Caroline, Garbe, Claus, Chang, Ilsung, Hack, Stephen P, Ribas, Antoni
Published in J Transl Med (2015)